5.8k total citations 317 papers, 4.0k citations indexed
About
Miguel N. Burnier is a scholar working on Ophthalmology, Molecular Biology and Oncology.
According to data from OpenAlex, Miguel N. Burnier has authored 317 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Ophthalmology, 76 papers in Molecular Biology and 75 papers in Oncology. Recurrent topics in Miguel N. Burnier's work include Ocular Oncology and Treatments (135 papers), Corneal Surgery and Treatments (30 papers) and Glaucoma and retinal disorders (29 papers). Miguel N. Burnier is often cited by papers focused on Ocular Oncology and Treatments (135 papers), Corneal Surgery and Treatments (30 papers) and Glaucoma and retinal disorders (29 papers). Miguel N. Burnier collaborates with scholars based in Canada, Brazil and United States. Miguel N. Burnier's co-authors include Bruno F. Fernandes, E. Antecka, Rubens Belfort, Alexandre Nakao Odashiro, Patrick Logan, S. Maloney, Ian W. McLean, Vinicius S. Saraiva, Sebastian Di Cesare and Sonia Callejo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer.
In The Last Decade
Miguel N. Burnier
299 papers
receiving
3.9k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Miguel N. Burnier
Since
Specialization
Citations
This map shows the geographic impact of Miguel N. Burnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel N. Burnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel N. Burnier more than expected).
Fields of papers citing papers by Miguel N. Burnier
This network shows the impact of papers produced by Miguel N. Burnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel N. Burnier. The network helps show where Miguel N. Burnier may publish in the future.
Co-authorship network of co-authors of Miguel N. Burnier
This figure shows the co-authorship network connecting the top 25 collaborators of Miguel N. Burnier.
A scholar is included among the top collaborators of Miguel N. Burnier based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Miguel N. Burnier. Miguel N. Burnier is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Abdouh, Mohamed, et al.. (2021). Effects of Spectrum of Wavelengths of Blue-Light on Retinal Pigment Epithelial Cells. Investigative Ophthalmology & Visual Science. 62(8). 266–266.2 indexed citations
Burnier, Miguel N., et al.. (2016). Deleted in Liver Cancer-1 (DLC-1) is highly expressed in conjunctival squamous neoplasia and acts as an oncogene in high grade lesions. Investigative Ophthalmology & Visual Science. 57(12). 2408–2408.1 indexed citations
7.
Barros, Paulo S.M., et al.. (2010). Histopathological Evaluation of Pigmented Intraocular Tumors in Dogs. Investigative Ophthalmology & Visual Science. 51(13). 5159–5159.1 indexed citations
Maloney, S., et al.. (2008). Hif-1 Expression in Choroidal Neovascular Membranes: Further Evidence Of Hypoxia as a Possible Key Factor in the Pathogenesis of Neovascular AMD. Investigative Ophthalmology & Visual Science. 49(13). 3410–3410.1 indexed citations
Arthurs, Bryan, et al.. (2006). Basal Cell Carcinoma of the Caruncle. Ophthalmic Plastic and Reconstructive Surgery. 22(4). 313–314.9 indexed citations
12.
Odashiro, Alexandre Nakao, et al.. (2005). The Cyclooxygenase–2 Inhibitor Nepafenac Improves the Function of Macrophages Suppressed by Uveal Melanoma Conditioned Medium. Investigative Ophthalmology & Visual Science. 46(13). 3407–3407.1 indexed citations
13.
Saraiva, Vinicius S., et al.. (2004). Inhibition of uveal melanoma cell proliferation by nepafenac, a selective cyclooxygenase–2 (COX–2) inhibitor. Investigative Ophthalmology & Visual Science. 45(13). 1204–1204.1 indexed citations
14.
Blanco, Paula, et al.. (2003). The Value of Ultrasound as a Tool to Evaluate Uveal Melanoma in a Rabbit Model. Investigative Ophthalmology & Visual Science. 44(13). 3649–3649.1 indexed citations
15.
Blanco, Paula, et al.. (2003). Immunohistochemical Evaluation of Migration Inhibitory Factor (MIF) in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 44(13). 1546–1546.1 indexed citations
16.
Callejo, Sonia, et al.. (2003). Detection of Spiked Uveal Melanoma Cells in Peripheral Blood of Healthy Volunteers. Investigative Ophthalmology & Visual Science. 44(13). 1550–1550.2 indexed citations
17.
Méndez, María, et al.. (2002). Cyclooxygenase-2 (COX-2) Expression in Malignant Uveal Melanoma: Its Role in Disease Progression. Investigative Ophthalmology & Visual Science. 43(13). 1134–1134.1 indexed citations
18.
Burnier, Miguel N., et al.. (2002). Correlation of Cyclooxygenase-2 (COX-2) Expression and Interconverted Phenotype in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 43(13). 1143–1143.1 indexed citations
19.
Barros, Paulo S.M., et al.. (1995). Surgical repair of the cornea of the dog using pericardium as a keratoprosthesis. Brazilian Journal of Veterinary Research and Animal Science. 32(4).10 indexed citations
20.
Barros, Paulo S.M., et al.. (1990). Repair of the sclera and 3rd eyelid using heterologous pericardium . An experimental study. 1. 9.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.